Weihong Xu
-
- Cancer-related molecular mechanisms research 2
-
- Autophagy in Disease and Therapy 2
-
- Inflammasome and immune disorders 3
- RNA modifications and cancer 3
-
- Selenium in Biological Systems 1
-
- Bone health and treatments 1
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
-
- Genetic Associations and Epidemiology 1
- Journals
- Cancer Research (1 paper)Biochemical and Biophysical Research Communications (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weihong Xu
17 papers receiving 483 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 83
- Epidemiology 170
- Molecular Biology 280
- Cell Biology 59
- Physiology 15
Countries citing papers authored by Weihong Xu
This map shows the geographic impact of Weihong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Xu more than expected).
Fields of papers citing papers by Weihong Xu
This network shows the impact of papers produced by Weihong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Xu. The network helps show where Weihong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weihong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 9 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 60 | |
| 8 | 2021 | 2 | |
| 9 | 2019 | 21 | |
| 10 | 2019 | 26 | |
| 11 | 2018 | 35 | |
| 12 | 2018 | 14 | |
| 13 | 2017 | 3 | |
| 14 | 2017 | 10 | |
| 15 | 2017 | 10 | |
| 16 | Overexpression and biological function of IQGAP3 in human pancreatic cancer. | 2016 | 33 |
| 17 | 2015 | 14 | |
| 18 | 2015 | 2 | |
| 19 | 2014 | 52 | |
| 20 | 2007 | 180 |
About Weihong Xu
Weihong Xu is a scholar working on Periodontics, Cancer Research and Endocrinology, having authored 20 papers that have together received 489 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (3 papers), RNA modifications and cancer (3 papers), Autophagy in Disease and Therapy (2 papers), Cancer-related molecular mechanisms research (2 papers), Selenium in Biological Systems (1 paper), Bone health and treatments (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Genetic Associations and Epidemiology (1 paper). The work is most often cited by research in Cancer Research (83 citations), Epidemiology (170 citations) and Molecular Biology (280 citations). Weihong Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Haiyan Qi, Shengkan Jin, Yong Zhang, Bill Taylor, Leroy F. Liu, Huiming Sheng, Yanyun Ma, Jiucun Wang, Guihua Wang and Xiaoling Lv. Their work appears in journals such as Cancer Research, Biochemical and Biophysical Research Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.